Irritable Bowel Syndrome News

A recent study revealed a correlation between endometriosis and irritable bowel syndrome among adolescents and women with and without endometriosis.

Survey results revealed most internists perceived proton pump inhibitors were linked with numerous adverse events and recommended their discontinuation even in patients who are high risk for upper gastrointestinal bleeding.

Researchers found a link between frailty and risk for infection following immunosuppression in patients with inflammatory bowel disease after adjusting for age and comorbidities.

In this exclusive video perspective from the GUILD Conference 2020, Lin Chang, MD, from the David Geffen School of Medicine at the University of California, Los Angeles, discusses her presentation on updates in irritable bowel syndrome.

Factors like reduced disease severity and lower depression scores were associated with better satisfaction scores among patients with irritable bowel syndrome, according to study results.

Many patients with chronic constipation or constipation-predominant irritable bowel syndrome are dissatisfied with their current medications, according to study results.

In this guest commentary, Eric D. Shah, MD, MBA, director of the Gastrointestinal Motility Center at Dartmouth-Hitchcock Medical Center, discusses his recent study on abdominal pain in irritable bowel syndrome and argues that stratifying patients could evolve past bowel habits alone.

The presentation and characteristics of abdominal pain are not the same among the different subtypes of irritable bowel syndrome, according to study results.

As we enter the 6th year of Healio Gastroenterology and Liver Disease, it is worth looking back at what made us stand out in 2019: the Peer Tested content from online and print as it fared throughout the year.

More than 25% of adults in the United States, Canada and United Kingdom fit the Rome IV criteria for at least one of the six functional bowel disorders, according to study results.